Floatz logo

Vigabatrin

Glucose Intolerance

University of ArizonaSmall moleculePhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the Glucose Intolerance cohort.

Asset / SponsorPhaseRating
DULAGLUTIDE
University of Pennsylvania
Phase 4BBB
NEPENTHE
Washington University School of Medicine
Phase 4BB
DULAGLUTIDE
The University of Texas Health Science Center, Houston
Phase 4BB
Bxcl501
Pontificia Universidad Catolica de Chile
Phase 4BB
CYANOCOBALAMINUM
The University of Texas Health Science Center, Houston
Phase 4BB

View all 16 →

Same molecule, other indications

Vigabatrin is also rated in:

infantile spasmsDormant
BB
Indicative ·
66 / 100
View asset →
Adult Refractory Complex Partial SeizuresDormant
BB
Indicative ·
64 / 100
View asset →
tuberous sclerosisDormant
BB
Indicative ·
64 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →